(-)-Epigallocatechin-3-gallate inhibits the replication cycle of hepatitis C virus.
about
Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green teaBioavailability of dietary polyphenols and gut microbiota metabolism: antimicrobial propertiesGreen tea phenolic epicatechins inhibit hepatitis C virus replication via cycloxygenase-2 and attenuate virus-induced inflammation.Plant extracts from Cameroonian medicinal plants strongly inhibit hepatitis C virus infection in vitroPan-genotypic Hepatitis C Virus Inhibition by Natural Products Derived from the Wild Egyptian ArtichokeMEAN inhibits hepatitis C virus replication by interfering with a polypyrimidine tract-binding protein.Grape Seed Extract Attenuates Hepatitis C Virus Replication and Virus-Induced Inflammation.Hepatitis C virus and natural compounds: a new antiviral approach?Review article: management of chronic hepatitis C in patients with contraindications to anti-viral therapy.An ERp57-mediated disulphide exchange promotes the interaction between Burkholderia cenocepacia and epithelial respiratory cellsA Review of the Antiviral Role of Green Tea Catechins.Flavonoids: promising natural compounds against viral infections.Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action.Nutritional Epigenetics and the Prevention of Hepatocellular Carcinoma with Bioactive Food Constituents.In vitro evaluation of the antiviral activity of the synthetic epigallocatechin gallate analog-epigallocatechin gallate (EGCG) palmitate against porcine reproductive and respiratory syndrome virus.In Vitro Study on Anti-Hepatitis C Virus Activity of Spatholobus suberectus Dunn.In silico studies of medicinal compounds against hepatitis C capsid protein from north India.Evaluation of green tea extract as a safe personal hygiene against viral infections.In silico analysis of natural compounds targeting structural and nonstructural proteins of chikungunya virus.Anti-infective potential of catechins and their derivatives against viral hepatitis.Plant-derived antivirals against hepatitis c virus infection.
P2860
Q26852556-E91833B4-97E7-4989-8FC8-C92B549BC5FFQ27001250-05095C9F-3E06-4DAC-B5BD-5F9D642D5E6CQ34568343-847C4D91-5C63-42AF-A545-CF07BE8100CDQ35609156-F28C62F3-A186-41E4-9CA4-F253FE88A816Q36524016-86FD74CF-07AF-42C2-862B-810B91C0D2DDQ37057008-C2BB4CE7-893B-43D2-8E99-E7047B7B2019Q37521412-969DE19F-14D1-4AAB-9C60-E0CEFAECE9EBQ38064280-D036E8C6-9435-44D5-BEBD-FF63ABABBBADQ38166445-6CC9A35A-139B-44A8-A3B0-3B10E32CC05CQ38480787-C72DDD9B-E162-4EEA-A9A7-F61EA01C6DC6Q38626136-6D2456B8-B1A4-4033-9379-8FBE0A0E8813Q38678630-53BABEA2-2AF6-47FC-85EF-4F6A647E93F1Q38850319-FBBC5051-7869-40FA-B6CF-BA79998D8857Q38856299-D84253DC-8015-45C4-95DC-2B88EA3D0FADQ39021179-30D6956C-76DF-4958-905E-B6D58D01470FQ40501654-A27FD647-A69A-4FFE-ABC9-A3FC07FD2325Q41539117-039697DE-D24A-4B2E-9BE8-CB5AE1C6BF30Q47552747-07C3F17C-FF2A-451C-9594-743C221C0D74Q47553566-3D8D9AED-371B-424A-8718-0C809109A0F8Q48109129-E5A30012-7DED-4FB9-A2FA-F64F27C422CAQ49197977-F2483E26-BDB3-4517-9B1A-D7BB666E447D
P2860
(-)-Epigallocatechin-3-gallate inhibits the replication cycle of hepatitis C virus.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
(-)-Epigallocatechin-3-gallate inhibits the replication cycle of hepatitis C virus.
@en
type
label
(-)-Epigallocatechin-3-gallate inhibits the replication cycle of hepatitis C virus.
@en
prefLabel
(-)-Epigallocatechin-3-gallate inhibits the replication cycle of hepatitis C virus.
@en
P2093
P2860
P1433
P1476
(-)-Epigallocatechin-3-gallate inhibits the replication cycle of hepatitis C virus.
@en
P2093
Bin-Lian Sun
Rong-Ge Yang
Xin-Wen Chen
P2860
P2888
P304
P356
10.1007/S00705-012-1304-0
P577
2012-04-11T00:00:00Z